Back to search
FDAFDA · Food and drugs·Recall number D-0163-2016

Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.

Published November 11, 2015 · Recall initiated: September 4, 2015

Summary

FDA records drug Class II recall D-0163-2016, published November 11, 2015 and initiated September 4, 2015. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 3341 Bottles; Lot: Lot # 1300939, Expiry: March 2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Failed 24 month dissolution testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valeant Pharmaceuticals North America LLC
Distributor
U.S. Nationwide
Lot
Lot # 1300939, Expiry: March 2016.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90. recalled?

Yes. FDA published recall D-0163-2016 on November 11, 2015. Reported hazard: Failed Dissolution Specifications: Failed 24 month dissolution testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter